Table 1.
Patients and surgery characteristics
| Group A (n = 41) | Group B (n = 44) | Group C (n = 42) | P value | |
|---|---|---|---|---|
| Age (yr) |
49 (21–65) |
48 (27–65) |
53 (23–64) |
0.677 |
| Weight (kg) |
62 ± 11 |
62 ± 11 |
63 ± 11 |
0.894 |
| Height (cm) |
162 ± 8 |
163 ± 8 |
163 ± 9 |
0.728 |
| Gender (M/F) |
14/27 |
19/25 |
13/29 |
0.471 |
| Preoperative dexamethasone |
17 (41) |
15 (34) |
11 (26) |
0.339 |
| Operation time (min) |
249 ± 87 |
288 ± 117 |
254 ± 110 |
0.179 |
| Anesthesia time (min) |
321 ± 90 |
368 ± 131 |
327 ± 114 |
0.110 |
| Type of surgery |
|
|
|
0.322 |
| Tumor surgery |
26 (63) |
26 (59) |
20 (48) |
|
| Vascular surgery |
15 (37) |
18 (41) |
22 (52) |
|
| ASA class I/II |
24 (59)/17 (41) |
22 (50)/22 (50) |
22 (52)/20 (48) |
0.720 |
| Preexisting disease, (n) |
|
|
|
|
| Hypertension |
11 |
13 |
13 |
0.916 |
| Diabetes mellitus |
4 |
5 |
7 |
0.609 |
| Liver disease | 3 | 2 | 0 | 0.223 |
Group A; ondansetron 4 mg group. Group B; ondansetron 8 mg group. Group C; ramosetron 0.3 mg group. Values are expressed as mean (SD) or number of the patients (n) except age (mean, range).